<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A0397DD-E0C6-4EA3-8031-B841D2503C4D"><gtr:id>7A0397DD-E0C6-4EA3-8031-B841D2503C4D</gtr:id><gtr:name>Royal Holloway, University of London</gtr:name><gtr:address><gtr:line1>Egham Hill</gtr:line1><gtr:line4>Egham</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>TW20 0EX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A0397DD-E0C6-4EA3-8031-B841D2503C4D"><gtr:id>7A0397DD-E0C6-4EA3-8031-B841D2503C4D</gtr:id><gtr:name>Royal Holloway, University of London</gtr:name><gtr:address><gtr:line1>Egham Hill</gtr:line1><gtr:line4>Egham</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>TW20 0EX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CBCDFD85-C995-44E2-8752-39DF1561D6E6"><gtr:id>CBCDFD85-C995-44E2-8752-39DF1561D6E6</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:surname>Patterson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A5EEF8B8-F133-43A5-8E49-CA03803B21B5"><gtr:id>A5EEF8B8-F133-43A5-8E49-CA03803B21B5</gtr:id><gtr:firstName>Frances</gtr:firstName><gtr:otherNames>M</gtr:otherNames><gtr:surname>Gotch</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0100482"><gtr:id>B0D657EC-AEA8-4DE1-8A28-F9DB60E9414F</gtr:id><gtr:title>Dendritic cells: the key to understanding HIV pathogenesis and HIV vaccine development</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0100482</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-08-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-02-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>759425</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>Gates CAVD HIV vaccine grant</gtr:description><gtr:id>9AF73D08-6700-4494-9D33-426727227E03</gtr:id><gtr:impact>Recently we have proposed a hypothesis to explain why in the HIV vaccine STEP trial using adenovirus vectors there was an increased number of infections in the vaccianted group. Experiments testing the hypothesis are described in PNAS- PMID: 19918060</gtr:impact><gtr:outcomeId>067C2EFBE9F-2</gtr:outcomeId><gtr:partnerContribution>Production of viral vectors for in vitro human studiesTesting vaccine constructs in murine model</gtr:partnerContribution><gtr:piContribution>We are funded to develop an adenovirus vector HIV T cell vaccine targeted to skin dendritic cells that is designed to induce a broad CD8 T cell response. Our contribution is in providing experitse human dendritic cell biology, particularly skin dendritic cells, and antigen processing.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Holloway, University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences</gtr:department><gtr:description>Gates CAVD HIV vaccine grant</gtr:description><gtr:id>AAE9F0C2-EF8F-41EA-AFF6-74F1B219F87B</gtr:id><gtr:impact>Recently we have proposed a hypothesis to explain why in the HIV vaccine STEP trial using adenovirus vectors there was an increased number of infections in the vaccianted group. Experiments testing the hypothesis are described in PNAS- PMID: 19918060</gtr:impact><gtr:outcomeId>067C2EFBE9F-1</gtr:outcomeId><gtr:partnerContribution>Production of viral vectors for in vitro human studiesTesting vaccine constructs in murine model</gtr:partnerContribution><gtr:piContribution>We are funded to develop an adenovirus vector HIV T cell vaccine targeted to skin dendritic cells that is designed to induce a broad CD8 T cell response. Our contribution is in providing experitse human dendritic cell biology, particularly skin dendritic cells, and antigen processing.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio interview BBC World Service (2009)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>85ECBF38-0A65-475A-AA8E-C12A53A3949C</gtr:id><gtr:impact>Radio interview prompted by a paper that we published proposing underlying reasons for the adverse effects of an HIV vaccine trial

Reports in international press</gtr:impact><gtr:outcomeId>Tm45k7Ujqcz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5000000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Gates funding</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>315C3051-70F7-4398-BF52-2514B6B88B89</gtr:id><gtr:outcomeId>8AF1B0466A70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>An adenovirus HIv vaccine is being developed in which the virus is coated with a polymer and targeted to skin dendritic cells by the attachment of a TLR2 ligand to the polymer</gtr:description><gtr:id>C45138CC-6BB6-41CE-968B-4169687452F4</gtr:id><gtr:impact>Our consortium developing the HIV vaccine is one of the groups in the Collaboration for AIDS Vaccine Development programme supported by the Gates Foundation.</gtr:impact><gtr:outcomeId>1864CD9E5BA</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Closed</gtr:status><gtr:title>HIV vaccine targeting skin dendritic cells</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Our research was the first to demonstrate that dendritic cells are susceptible HIV infection and are progressivey lost during HIV infection</gtr:description><gtr:id>8C34180A-AA41-40F1-A2A5-3073A85A5897</gtr:id><gtr:impact>The observation that dendritic cells are susceptible to HIV infections have led to study by many groups of the role of these cells in HIV transmission, transmission of virus to T cells and monitoring of dendrtic cell numbers in HIV disease progression.</gtr:impact><gtr:outcomeId>C3655F9FDD2</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Analysis of blood dendritic cells</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BF210A33-C2A7-4EE8-B690-A5D94F54AB89</gtr:id><gtr:title>Use of adenovirus in vaccines for HIV.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/282ae484e5c075253c677437743d1964"><gtr:id>282ae484e5c075253c677437743d1964</gtr:id><gtr:otherNames>Patterson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn><gtr:outcomeId>D9E5CC01EFD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E32048F-AAB1-4E24-820B-90FCAEC573E4</gtr:id><gtr:title>Activity of different vaccine-associated promoter elements in human dendritic cells.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a223180641c79320933b477354035bc"><gtr:id>9a223180641c79320933b477354035bc</gtr:id><gtr:otherNames>Papagatsias T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn><gtr:outcomeId>63BC97C49B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF253DB7-41D6-45DE-84D2-E00C5196BB1D</gtr:id><gtr:title>Human blood CD1c dendritic cells stimulate IL-12-independent IFN-responses and have a strikingly low inflammatory profile.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b31587f34c13d4d8e683294e95790d"><gtr:id>d8b31587f34c13d4d8e683294e95790d</gtr:id><gtr:otherNames>Benlahrech A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>585d6208482a18.34159286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F91B10-D51E-4097-A11C-70C578F14270</gtr:id><gtr:title>Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b31587f34c13d4d8e683294e95790d"><gtr:id>d8b31587f34c13d4d8e683294e95790d</gtr:id><gtr:otherNames>Benlahrech A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>JnG35kfCXvu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05155068-0660-45AF-A8E4-0C66350224C8</gtr:id><gtr:title>TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc90e0da9879623c732f0fd58f7890c7"><gtr:id>fc90e0da9879623c732f0fd58f7890c7</gtr:id><gtr:otherNames>Duraisingham SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>WZVKKu9B479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57FA17AB-3638-48B7-9CDA-0EF405CFDA8E</gtr:id><gtr:title>Fragmentation of SIV-gag vaccine induces broader T cell responses.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b31587f34c13d4d8e683294e95790d"><gtr:id>d8b31587f34c13d4d8e683294e95790d</gtr:id><gtr:otherNames>Benlahrech A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15507_27_23118924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E47884FF-FB91-4BF8-BAAA-A4CEE2A25226</gtr:id><gtr:title>Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b31587f34c13d4d8e683294e95790d"><gtr:id>d8b31587f34c13d4d8e683294e95790d</gtr:id><gtr:otherNames>Benlahrech A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>pm_15507_27_23039892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49B7470C-96D2-46AE-9B99-CD1E035B10C3</gtr:id><gtr:title>HIV-1 infection and induction of interferon alpha in plasmacytoid dendritic cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in HIV and AIDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b31587f34c13d4d8e683294e95790d"><gtr:id>d8b31587f34c13d4d8e683294e95790d</gtr:id><gtr:otherNames>Benlahrech A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1746-630X</gtr:issn><gtr:outcomeId>fGwvMdd3dVL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A17173D8-2D3C-49A7-AA42-D3228541D042</gtr:id><gtr:title>Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02392ae529e06175e91d6ba0c608972d"><gtr:id>02392ae529e06175e91d6ba0c608972d</gtr:id><gtr:otherNames>Buisson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>D113586B3FC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2FBA42D-8565-4555-914C-EC58476933C6</gtr:id><gtr:title>Efficient liver-directed gene transfer by in situ generation of retroviral vector from adenoviral templates.</gtr:title><gtr:parentPublicationTitle>In vivo (Athens, Greece)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2edc81ec7442dcb104f3609b38c6ef13"><gtr:id>2edc81ec7442dcb104f3609b38c6ef13</gtr:id><gtr:otherNames>Harris JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0258-851X</gtr:issn><gtr:outcomeId>pm_15507_27_20023229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A95B6472-999F-4CF8-BA24-F74E285586CE</gtr:id><gtr:title>CD34-derived human Langerhans cells stimulate a T helper type 2 response independently of extracellular-signal-regulated kinase phosphorylation.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc90e0da9879623c732f0fd58f7890c7"><gtr:id>fc90e0da9879623c732f0fd58f7890c7</gtr:id><gtr:otherNames>Duraisingham SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>jAAAJU4FdmV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B8FD4B4-E2D7-429C-98B3-DCD11330A7D9</gtr:id><gtr:title>Human NK Cell Up-regulation of CD69, HLA-DR, Interferon ? Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways.</gtr:title><gtr:parentPublicationTitle>Sensors (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b31587f34c13d4d8e683294e95790d"><gtr:id>d8b31587f34c13d4d8e683294e95790d</gtr:id><gtr:otherNames>Benlahrech A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1424-8220</gtr:issn><gtr:outcomeId>A932339A3C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AD84B00-416C-474E-AD50-B2A4D8767885</gtr:id><gtr:title>Human Langerhans' cells and dermal-type dendritic cells generated from CD34 stem cells express different toll-like receptors and secrete different cytokines in response to toll-like receptor ligands.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29025976bcc8ac7edac8784500c55400"><gtr:id>29025976bcc8ac7edac8784500c55400</gtr:id><gtr:otherNames>Rozis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>BC062C036A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8756A3D-AED6-4944-875E-F81391071E9B</gtr:id><gtr:title>Expression of a versatile DC-targeting fusion protein using an Adenovirus expression system.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb7ca226401255e1dbd587087f19ef7"><gtr:id>bcb7ca226401255e1dbd587087f19ef7</gtr:id><gtr:otherNames>Pillay S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn><gtr:outcomeId>pm_15507_27_22728768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAE1D698-31BF-4620-B243-8E6C3D5ACFB9</gtr:id><gtr:title>Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b31587f34c13d4d8e683294e95790d"><gtr:id>d8b31587f34c13d4d8e683294e95790d</gtr:id><gtr:otherNames>Benlahrech A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>jMHDq2P5GjQ</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0100482</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>